$NKTR NEKTAR THERAPEUTICS Insider Trading Week 45/2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NEKTAR THERAPEUTICS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NEKTAR THERAPEUTICS in week 45/2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 08 2017 | NKTR | NEKTAR THERAPEUTIC ... | Hora Maninder | SVP Pharma Dev & Mf ... | Option Exercise | M | 10.69 | 17,300 | 184,937 | 0 | |
| Nov 08 2017 | NKTR | NEKTAR THERAPEUTIC ... | Hora Maninder | SVP Pharma Dev & Mf ... | Option Exercise | M | 10.69 | 5,117 | 54,701 | 17,300 | |
| Nov 08 2017 | NKTR | NEKTAR THERAPEUTIC ... | Hora Maninder | SVP Pharma Dev & Mf ... | Sell | M | 25.51 | 17,300 | 441,323 | 58,233 | 75.5 K to 58.2 K (-22.90 %) |
| Nov 08 2017 | NKTR | NEKTAR THERAPEUTIC ... | Hora Maninder | SVP Pharma Dev & Mf ... | Buy | M | 10.69 | 17,300 | 184,937 | 75,533 | 58.2 K to 75.5 K (+29.71 %) |
| Nov 08 2017 | NKTR | NEKTAR THERAPEUTIC ... | Hora Maninder | SVP Pharma Dev & Mf ... | Sell | S | 25.07 | 5,117 | 128,283 | 58,233 | 63.4 K to 58.2 K (-8.08 %) |
| Nov 08 2017 | NKTR | NEKTAR THERAPEUTIC ... | Hora Maninder | SVP Pharma Dev & Mf ... | Buy | M | 10.69 | 5,117 | 54,701 | 63,350 | 58.2 K to 63.4 K (+8.79 %) |
| Nov 08 2017 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Option Exercise | M | 9.53 | 300,000 | 2,859,000 | 0 | |
| Nov 08 2017 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Option Exercise | M | 9.53 | 75,409 | 718,648 | 300,000 | |
| Nov 08 2017 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Option Exercise | M | 9.53 | 20,914 | 199,310 | 375,409 | |
| Nov 08 2017 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Sell | S | 30.09 | 300,000 | 9,027,000 | 31,102 | 331.1 K to 31.1 K (-90.61 %) |
| Nov 08 2017 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Buy | M | 9.53 | 300,000 | 2,859,000 | 331,102 | 31.1 K to 331.1 K (+964.57 %) |
| Nov 08 2017 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Sell | S | 25.78 | 75,409 | 1,944,044 | 31,102 | 106.5 K to 31.1 K (-70.80 %) |
| Nov 08 2017 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Buy | M | 9.53 | 75,409 | 718,648 | 106,511 | 31.1 K to 106.5 K (+242.46 %) |
| Nov 08 2017 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Sell | S | 24.98 | 20,914 | 522,432 | 31,102 | 52 K to 31.1 K (-40.21 %) |
| Nov 08 2017 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Buy | M | 9.53 | 20,914 | 199,310 | 52,016 | 31.1 K to 52 K (+67.24 %) |